Total Payments
$15,964
2024 Payments
$135.64
Companies
27
Transactions
119
Medicare Patients
3,800
Medicare Billing
$562,698
Payment Breakdown by Category
Consulting$5,750 (36.0%)
Education$4,100 (25.7%)
Food & Beverage$2,428 (15.2%)
Travel$2,045 (12.8%)
Other$1,640 (10.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,750 | 3 | 36.0% |
| Education | $4,100 | 2 | 25.7% |
| Food and Beverage | $2,428 | 111 | 15.2% |
| Travel and Lodging | $2,045 | 2 | 12.8% |
| Long term medical supply or device loan | $1,640 | 1 | 10.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $13,794 | 9 | $0 (2022) |
| Abbott Laboratories | $403.70 | 8 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $319.70 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $220.04 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $189.81 | 12 | $0 (2023) |
| Medtronic, Inc. | $170.97 | 1 | $0 (2022) |
| PFIZER INC. | $122.27 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $114.86 | 8 | $0 (2019) |
| Amgen Inc. | $112.39 | 9 | $0 (2023) |
| ABIOMED | $89.65 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.64 | 8 | Novartis Pharmaceuticals Corporation ($54.89) |
| 2023 | $155.91 | 10 | Amgen Inc. ($42.14) |
| 2022 | $2,835 | 4 | AngioDynamics, Inc. ($2,640) |
| 2021 | $6,850 | 3 | AngioDynamics, Inc. ($6,850) |
| 2020 | $2,094 | 8 | AngioDynamics, Inc. ($2,000) |
| 2019 | $2,538 | 19 | AngioDynamics, Inc. ($2,303) |
| 2018 | $339.34 | 24 | Novartis Pharmaceuticals Corporation ($89.01) |
| 2017 | $1,015 | 43 | Abbott Laboratories ($379.60) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.77 | General |
| Category: Cardiovascular | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology | ||||||
| 11/16/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/28/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular Device | ||||||
| 09/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/02/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $27.02 | General |
| Category: Wound Care | ||||||
| 05/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiology | ||||||
| 01/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology | ||||||
| 11/17/2022 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $170.97 | General |
| Category: Transcatheter Valve Systems | ||||||
| 09/27/2022 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 05/04/2022 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Long term medical supply or device loan | In-kind items and services | $1,640.00 | General |
| Category: ET | ||||||
| 03/02/2022 | AngioDynamics, Inc. | VENACURE 1470 PRO (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VIT | ||||||
| 12/31/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Education | In-kind items and services | $3,986.67 | General |
| Category: ET | ||||||
| 03/02/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Education | In-kind items and services | $113.75 | General |
| Category: VIT | ||||||
| 01/13/2021 | AngioDynamics, Inc. | VenaCure 1470 Pro (Device) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Endovascular Therapies | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 815 | 1,186 | $388,185 | $130,034 |
| 2022 | 12 | 915 | 1,250 | $399,783 | $139,891 |
| 2021 | 16 | 1,020 | 1,445 | $510,875 | $185,281 |
| 2020 | 17 | 1,050 | 1,392 | $401,081 | $107,492 |
Total Patients
3,800
Total Services
5,273
Medicare Billing
$562,698
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 17 | 26 | $65,000 | $31,906 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 260 | $75,787 | $25,440 | 33.6% |
| 36478 | Laser destruction of incompetent vein of arm or leg using imaging guidance | Office | 2023 | 20 | 25 | $62,500 | $22,621 | 36.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 77 | 84 | $49,800 | $13,707 | 27.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 37 | 86 | $34,400 | $9,311 | 27.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 112 | 112 | $29,185 | $5,937 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $14,454 | $4,993 | 34.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 19 | 19 | $7,600 | $3,970 | 52.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 40 | 158 | $13,206 | $3,468 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 24 | $11,549 | $3,289 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 122 | 190 | $11,041 | $2,109 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 21 | $5,020 | $1,420 | 28.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 71 | 71 | $5,183 | $1,105 | 21.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 71 | 71 | $3,461 | $758.94 | 21.9% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 21 | 42 | $105,000 | $55,250 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 290 | $92,138 | $29,565 | 32.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 213 | 213 | $55,504 | $13,373 | 24.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 56 | 62 | $37,200 | $10,772 | 29.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2022 | 33 | 87 | $34,800 | $9,243 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $19,858 | $6,114 | 30.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 17 | 17 | $6,800 | $3,864 | 56.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 23 | $11,199 | $3,167 | 28.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 53 | $12,669 | $3,104 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 150 | 256 | $14,876 | $3,049 | 20.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 79 | 80 | $5,840 | $1,431 | 24.5% |
About Dr. John Capitanelli, M.D
Dr. John Capitanelli, M.D is a Cardiovascular Disease healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538182688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Capitanelli, M.D has received a total of $15,964 in payments from pharmaceutical and medical device companies, with $135.64 received in 2024. These payments were reported across 119 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($5,750).
As a Medicare-enrolled provider, Capitanelli has provided services to 3,800 Medicare beneficiaries, totaling 5,273 services with total Medicare billing of $562,698. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location West Paterson, NJ
- Active Since 07/26/2006
- Last Updated 04/14/2008
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1538182688
Products in Payments
- VenaCure 1470 Pro (Device) $8,490
- VENACURE 1470 PRO (Device) $1,000
- ENTRESTO (Drug) $269.63
- XARELTO (Drug) $220.04
- BRILINTA (Drug) $176.77
- COREVALVE EVOLUT R (Device) $170.97
- Supera peripheral stent system (Device) $155.90
- Xience Alpine cornary stent system (Device) $128.71
- Absolute Pro vascular stent system (Device) $99.85
- ELIQUIS (Drug) $90.58
- Impella (Device) $89.65
- PRALUENT ALIROCUMAB INJECTION (Biological) $89.60
- Corlanor (Drug) $70.25
- VYNDAQEL (Drug) $64.87
- LEQVIO (Drug) $50.07
- Repatha (Biological) $42.14
- VARITHENA (Drug) $31.56
- Puraply (Medical Supply) $27.02
- Vascepa (Drug) $26.93
- PRALUENT (Biological) $25.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in West Paterson
Dr. Warren Maresca, M.d, M.D
Cardiovascular Disease — Payments: $16,547
Cardiovascular Disease $16,547
Dr. Anthony Losardo, M.d, M.D
Cardiovascular Disease — Payments: $2,311
Cardiovascular Disease $2,311
Dr. Raja'a Kaddaha, M.d, M.D
Cardiovascular Disease — Payments: $159.65
Cardiovascular Disease $159.65